Skip to Content
MilliporeSigma

Skip To

20275

Supelco

Amberlite XAD®-2

pkg of 100 g

Sign Into View Organizational & Contract Pricing

Select a Size

6 EA
₹2,150.00

₹2,150.00


Please contact Customer Service for Availability

Request a Bulk Order

Select a Size

Change View
6 EA
₹2,150.00

About This Item

CAS Number:
MDL number:
UNSPSC Code:
23151817

₹2,150.00


Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Agency

suitable for ASTM® D4861
suitable for EPA Method 10A, Method 23 and OTM-45

form

solid

packaging

pkg of 100 g

technique(s)

HPLC: suitable
LPLC: suitable

surface area

~300 m2/g

matrix

styrene-divinylbenzene (macroreticular)

matrix active group

polymer

particle size

20-60 mesh

pore size

~0.65 mL/g pore volume
90 Å mean pore size

density

1.02 g/mL at 25 °C (true wet)(lit.)
1.08 g/mL at 25 °C (skeletal)(lit.)

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
10357SU85300552672-U
matrix

styrene-divinylbenzene (macroreticular)

matrix

styrene-divinylbenzene (macroreticular)

matrix

styrene-divinylbenzene (macroreticular)

matrix

styrene-divinylbenzene (macroreticular)

pore size

~0.65 mL/g pore volume, 90 Å mean pore size

pore size

~0.65 mL/g pore volume, 90 Å mean pore size

pore size

~0.65 mL/g pore volume, 90 Å mean pore size

pore size

~0.65 mL/g pore volume, 90 Å mean pore size

matrix active group

polymer

matrix active group

polymer

matrix active group

polymer

matrix active group

polymer

particle size

20-60 mesh

particle size

20-60 mesh

particle size

20-60 mesh

particle size

20-60 mesh

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

technique(s)

HPLC: suitable, LPLC: suitable

technique(s)

HPLC: suitable, LPLC: suitable

technique(s)

LPLC: suitable, solid phase extraction (SPE): suitable

technique(s)

HPLC: suitable, LPLC: suitable

General description

Amberlite XAD-2, a hydrophobic copolymer of styrene-divinylbenzene resin, requires longer purification process and is commonly used as a sorbent.[1] Amberlite XAD-2 resin sorbs organic compounds depending upon the aromaticity and size of the hydrophobic groups through low-energy physical interactions.[2]
Nonionic macroreticular resin that adsorbs and releases ionic species through hydrophobic and polar interactions; usually used under isocratic conditions.
Specifications:

Application

  • Amberlite XAD®-2 was used as adsorbent in the extraction of organochlorine compounds using Soxhlat extraction technique.[3]
  • Amberlite XAD®-2 was used as adsorbent in the extraction of honey samples using column chromatography for HPLC analysis.[4]
  • Amberlite XAD®-2 was used in adsorption chromatography.[5]
Polyaromatic adsorbent resin for hydrophobic compounds up to MW 20,000: phenols, organic removal, surfactants, aroma compounds, antibiotic recovery. May be used as support for catalyst or metals removal. For cleaned US EPA versions, see Supelpak-2 and Supelpak-2B.
     

Legal Information

ASTM is a registered trademark of American Society for Testing and Materials
Amberlite is a trademark of DuPont de Nemours, Inc.
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Marc E De Broe
    Seminars in dialysis, 21(2), 142-144 (2008-02-06)
    The recent recognition of gadolinium (Gd) administration as a cause of nephrogenic systemic fibrosis (NSF) is a growing concern. The similarity of Gd and lanthanum (La), based on their place in the table of Mendeljev, has led to assumptions that
    Tilman B Drüeke
    Seminars in dialysis, 20(4), 329-332 (2007-07-20)
    Controlling serum phosphorus levels in patients with renal failure is critical. The use of oral phosphate-binding agents is universal for patients with end-stage kidney disease to reduce phosphate absorption. The therapeutic goal is to reduce serum phosphorus levels without disturbing
    M Cozzolino et al.
    The International journal of artificial organs, 30(4), 293-300 (2007-05-24)
    Phosphate overload is a dramatic consequence in end-stage renal disease (ESRD) patients. Recent studies have well documented that abnormalities in mineral and bone metabolism in these patients are associated with increased cardiovascular morbidity and mortality. Elevated serum phosphate and calcium-phosphate
    Gadolinium and lanthanum: a iatrogenic transmetallation?
    Simona Brambilla et al.
    Clinical biochemistry, 41(13), 1029-1033 (2008-06-19)
    Stephen J P Damment et al.
    Clinical pharmacokinetics, 47(9), 553-563 (2008-08-14)
    Lanthanum carbonate is considered to be the most potent of a new generation of noncalcium phosphate binders used to treat hyperphosphataemia in chronic kidney disease (CKD), a condition associated with progressive bone and cardiovascular pathology and a markedly elevated risk

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service